They suggested that vitamin C eradicated BRAF wild-type thyroid cancer cells through a ROS-mediated decrease in the activity of epidermal growth factor/epidermal growth factor receptor-MAPK/ERK signaling and an increase in AKT ubiquitination [69]. The gene discussed is AKT1; the disease is thyroid cancer.